Skip to main content
Journal cover image

Injectable, Dual-Cross-Linked, Dynamic Hydrogel for Tissue Separation and Thermal Shielding during Percutaneous Cryoablation.

Journal articles  - Journal Article
Shin, J; King, BH; Pal, S; Rezaian, B; Zoghi, S; Mastria, EM; Conrad, MB; Messersmith, PB
Published in: J Vasc Interv Radiol
June 2026

PURPOSE: To develop a biocompatible hydrogel for hydrodissection to facilitate percutaneous cryoablation. MATERIALS AND METHODS: A hydrogel was created by cross-linking alginate, calcium ions, and polyethylene glycol conjugated with boronic acid. Stability of the gel and maintenance of structural integrity were assessed utilizing serum-containing cell culture media. Mechanical properties of the hydrogel were studied using rheometric analysis, and insulation was assessed during repeat freeze-thaw cycles. Cytotoxicity was examined through direct and indirect contact tests using human fibroblasts. Cytokine tumor necrosis factor-α (TNF-α) release from mouse macrophages was measured as a surrogate for inflammatory effects. Tissue displacement, migration, and resorption of the hydrogel were explored following intraperitoneal instillation in mice using serial ultrasound (US) and magnetic resonance (MR) imaging. RESULTS: The hydrogel exhibited shear-thinning behavior upon injection and self-healing properties upon repeated mechanical manipulation. Additionally, the gel maintained its insulative properties during consecutive freeze-thaw cycles. Viability of human fibroblasts was similar when cultured with and without the hydrogel for 3 days (100% vs 92%, P = .65). In addition, TNF-α secretion from macrophages in the presence of the gel (123.8 pg/mL [SD ± 99.4]) was comparable to a no-treatment control (47.5 pg/mL [SD ± 15.6], P = .98). Gel injection into the mouse peritoneum achieved durable bowel displacement for 6 hours. Half of the gel remained at 24 hours, with nearly all the gel (95%) resorbed by 72 hours. CONCLUSIONS: This novel hydrogel demonstrated favorable biocompatibility and physical properties for achieving prolonged tissue separation and thermal shielding during cryoablation.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Vasc Interv Radiol

DOI

EISSN

1535-7732

Publication Date

June 2026

Volume

37

Issue

6

Start / End Page

108686

Location

United States

Related Subject Headings

  • Tumor Necrosis Factor-alpha
  • Time Factors
  • Polyethylene Glycols
  • Nuclear Medicine & Medical Imaging
  • Mice
  • Materials Testing
  • Male
  • Macrophages
  • Injections
  • Hydrogels
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Shin, J., King, B. H., Pal, S., Rezaian, B., Zoghi, S., Mastria, E. M., … Messersmith, P. B. (2026). Injectable, Dual-Cross-Linked, Dynamic Hydrogel for Tissue Separation and Thermal Shielding during Percutaneous Cryoablation. J Vasc Interv Radiol, 37(6), 108686. https://doi.org/10.1016/j.jvir.2026.108686
Shin, Jisoo, Bradley H. King, Subhajit Pal, Bita Rezaian, Shervin Zoghi, Eric M. Mastria, Miles B. Conrad, and Phillip B. Messersmith. “Injectable, Dual-Cross-Linked, Dynamic Hydrogel for Tissue Separation and Thermal Shielding during Percutaneous Cryoablation.J Vasc Interv Radiol 37, no. 6 (June 2026): 108686. https://doi.org/10.1016/j.jvir.2026.108686.
Shin J, King BH, Pal S, Rezaian B, Zoghi S, Mastria EM, et al. Injectable, Dual-Cross-Linked, Dynamic Hydrogel for Tissue Separation and Thermal Shielding during Percutaneous Cryoablation. J Vasc Interv Radiol. 2026 Jun;37(6):108686.
Shin, Jisoo, et al. “Injectable, Dual-Cross-Linked, Dynamic Hydrogel for Tissue Separation and Thermal Shielding during Percutaneous Cryoablation.J Vasc Interv Radiol, vol. 37, no. 6, June 2026, p. 108686. Pubmed, doi:10.1016/j.jvir.2026.108686.
Shin J, King BH, Pal S, Rezaian B, Zoghi S, Mastria EM, Conrad MB, Messersmith PB. Injectable, Dual-Cross-Linked, Dynamic Hydrogel for Tissue Separation and Thermal Shielding during Percutaneous Cryoablation. J Vasc Interv Radiol. 2026 Jun;37(6):108686.
Journal cover image

Published In

J Vasc Interv Radiol

DOI

EISSN

1535-7732

Publication Date

June 2026

Volume

37

Issue

6

Start / End Page

108686

Location

United States

Related Subject Headings

  • Tumor Necrosis Factor-alpha
  • Time Factors
  • Polyethylene Glycols
  • Nuclear Medicine & Medical Imaging
  • Mice
  • Materials Testing
  • Male
  • Macrophages
  • Injections
  • Hydrogels